JUNQ and IPOD

Last updated
Eukaryote cells sort misfolded proteins into two quality control compartments: JUNQ and IPOD, based on their ubiquitination state. A scheme of a yeast cell harboring JUNQ and IPOD inclusions.png
Eukaryote cells sort misfolded proteins into two quality control compartments: JUNQ and IPOD, based on their ubiquitination state.

JUNQ and IPOD are types of cytosolic protein inclusion bodies in eukaryotes.

Contents

Neurodegenerative diseases, such as Parkinson's, Alzheimer's, and Huntington's, are associated and correlated with protein aggregation and accumulation of misfolded proteins in inclusion bodies. For many years, protein aggregation was considered a random process by which misfolded proteins stick to each other to form inclusions [1] (imagine a bundle of hairs haphazardly piling up in a corner of a room). Moreover, protein aggregates were thought to be toxic agents and the cause for neuronal dysfunction and death. However, recent studies, using advanced methods (i.e. fluorescence microscopy), show that protein aggregation may actually be a tightly regulated, organized process, by which the cell protects itself from toxic proteins by sequestration to inclusion bodies. [2] In 2008, the Frydman lab showed that eukaryotic cells sort misfolded proteins into two distinct inclusion bodies in a well-managed cellular process: [3]

  1. The JUNQ (JUxta Nuclear Quality control compartment)
  2. The IPOD (Insoluble Protein Deposit)

JUNQ and IPOD are evolutionarily conserved, and are found in specific and defined cellular sites. Delivery of misfolded, aggregated proteins to JUNQ and IPOD require an intact cytoskeleton and specific cellular quality control components, such as Heat Shock Proteins (HSPs). [4] The partition into the two distinct inclusion bodies is due to the different handling and processing of different kinds of misfolded proteins (e.g. ubiquitinated vs. non-ubiquitinated proteins). Segregation of toxic protein aggregates into JUNQ and IPOD inclusion bodies is a means by which mammalian cells can be rejuvenated through asymmetric division. [5]

Thus, the discovery of JUNQ and IPOD provided a new striking perspective of how cells manage misfolded aggregated proteins and gave convincing proof that protein aggregation is a non-random, well regulated and controlled cellular process. Furthermore, the discovery of JUNQ and IPOD suggested that in addition to temporal quality control (i.e. time dependent administration of damaged proteins) cells exploit homeostasis spatially: [6] If degradation isn't available, protection of the cellular environment from a misfolded protein is accomplished by its sequestration to an aggregate inclusion.[ citation needed ]

Background

To function properly, most proteins must preserve a low-energy, three-dimensional structure known as the native state. The stability of a protein is tightly regulated through all its life stages: from cradle, as it is synthesized at the ribosome, through folding or assembly, till grave – when the protein is degraded and cleared from the cellular environment. [7] Protein homeostasis (proteostasis), [8] results from the coordinated action of the different arms of the cellular quality control system: molecular chaperones, proteases and other regulatory factors. Hence, cellular viability depends on timely and efficient management of misfolded proteins. Such management, by the quality control machinery, includes recognition of the misfolded protein by chaperones and E3 ligases, ubiquitination and degradation.[ citation needed ]

Proteostasis collapse, due to damage, stress, mutations, and aging, has been implicated as a basis for a large number of common human disorders, such as neurodegenerative diseases. [9] Although caused by different kinds of mutated proteins (e.g. in Huntington's disease – the protein Huntingtin) and disruptive to distinct tissues (e.g. in Huntington's disease – the striatum), such diseases share a common feature: accumulation of misfolded proteins in inclusion bodies. Thus, it was thought that the inclusion bodies are the cause of such diseases. However, the nature and characteristics of those intra-cellular inclusion bodies stayed elusive. Different kinds of proteins (e.g. prions, ERAD substrates) were reported to form different kinds of inclusion bodies (e.g. aggresomes, amyloids), yet it remained obscure if those observations combine into one and relate to the same sub-cellular site. Moreover, the pathways leading to inclusion formation and the involvement of the cellular protein quality control machinery were undefined and unknown. Thus, a systematic study providing a comprehensive understanding of protein aggregation and inclusion bodies was required. The discovery of JUNQ and IPOD [3] suggested new insights of how the cell manages different kinds of misfolded proteins and offered a novel framework for putting together the great puzzle of protein aggregation. [2]

Eukaryote cells sort misfolded proteins, based on their ubiquitination state, into two quality control compartments: 1. JUNQ (green), which is tethered to the nucleus (orange) 2. IPOD(green), which is tethered to the vacuole (black shadow) A cell harboring JUNQ and IPOD inclusions.png
Eukaryote cells sort misfolded proteins, based on their ubiquitination state, into two quality control compartments: 1. JUNQ (green), which is tethered to the nucleus (orange) 2. IPOD(green), which is tethered to the vacuole (black shadow)

Discovery

The fate of misfolded proteins and the process leading to the formation of aggregate inclusions, were initially studied using biochemical methods (e.g. western blotting).[ citation needed ]

Deeper insights into the biological process of protein quality control and aggregation was made possible by a novel approach to looking at this problem, termed "Live Cell Imaging". [10]

Live cell imaging enables in vivo tracking of proteins in space and time, in their natural endogenous environment. Thus, such a method provides more information about the dynamics and stages of biological events and processes. The method takes advantage of the easily detectable fluorescent proteins fused to a protein of interest, which can then be followed inside a cell using a fluorescence microscope. The cell may then be treated by a perturbation of interest (e.g. a drug, expression of a misfolded protein), and various properties of the fluorescently tagged protein can be assayed using time-lapse microscopy:

  1. Changes of the fluorescence level indicates changes of expression levels (i.e. higher levels = upregulation of a protein)
  2. Changes of localization (e.g. entrance of a protein from the cytosol to the nucleus)
  3. Solubility (e.g. by using the FRAP assay [11] )
  4. Interplay with the intracellular environment (e.g. by using the FLIP assay [11] )

In order to monitor the fate of cytosolic misfolded proteins in vivo , a plasmid carrying a GFP tagged folding reporter was cloned. The folding reporter, a model protein for aggregation, was a Ubc9 (SUMO-conjugating enzyme) mutant (UBC9ts), harboring a missense mutation (Y68L) with a temperature- sensitive (ts) phenotype. [12] [13] The marginally stable Ubc9ts is fully functional under physiological permissive conditions (25 °C) due to active cellular chaperones. The GFP–Ubc9ts was transformed into yeast and visualized using a fluorescence microscope.[ citation needed ]

Monitoring the folding sensor GFP–Ubc9ts was thought to indicate the cellular proteostasis, and to assay the ability of the cellular protein quality control system to deal with various kinds of stress. It was then observed that under normal conditions, GFP–Ubc9ts is diffused in the nucleus and in the cytosol. However, upon heat shock, GFP–Ubc9ts formed cytosolic punctate structures. Strikingly, when the proteasome was impaired and clearance of the misfolded protein by degradation was blocked, two distinct cytosolic inclusions were observed to be formed. Standard and conservative biochemical methods, such as cell fractionation and western blotting would not have revealed the partition into the two types of cytosolic aggregates.[ citation needed ]

The two detected inclusions were shown to be evolutionarily conserved quality control compartments, with different characteristics and distinct functions. They were named JUNQ (JUxta Nuclear Quality control compartment) and IPOD (Insoluble Protein Deposit), [3] and represent two cellular pathways for the sequestration and management of aggregation prone, potentially toxic proteins.[ citation needed ]

Partition of quality control substrates (i.e. misfolded proteins) to either compartment depends on their ubiquitination status and aggregation state (i.e. solubility):[ citation needed ]

Proteins that are ubiquitinated are delivered to the JUNQ, where they are processed for degradation by the proteasome. Misfolded proteins that are not ubiquitinated and terminally aggregated are sequestered to the IPOD.

Thus, the sub-cellular location of a misfolded protein (i.e. in the JUNQ or in the IPOD) provides information about its interaction with the cellular protein quality control machinery (e.g. its E3 ligase).

JUNQ

JUNQ is the JUxta Nuclear Quality control compartment.

A JUNQ inclusion viewed by a ubiquitinated VHL protein(green), is tethered to the nucleus (orange). JUNQ (green) tethered to the nucleus (orange).tif
A JUNQ inclusion viewed by a ubiquitinated VHL protein(green), is tethered to the nucleus (orange).

Significance

To maintain cellular homeostasis, the cellular quality control system must distinguish between folded and misfolded proteins. A misfolded protein will be recognized and tightly taken care of by either refolding or ubiquitination and proteasomal degradation.

However, cellular increase of misfolded protein loads, due to various kinds of stresses (e.g. heat shock), may saturate and exhaust the quality control machinery. In such cases, degradation of misfolded proteins is unavailable, and a second line of active cellular defense mechanism must be executed: directing misfolded proteins to specific cellular sites. [2]

The JUNQ serves as such a sequestration site. It was shown [3] that when the proteasome is impaired (e.g. by low expression levels of the proteasome subunit RPN11), ubiquitinated misfolded proteins are sorted into the JUNQ. Upon recovery from stress conditions (e.g. recovery from heat shock at a permissive temperature), misfolded proteins that accumulate in the JUNQ may be either refolded by the cellular chaperone machinery, or degraded by the 26S proteasome. Thus, the sequestration of a protein to the JUNQ is reversible.[ citation needed ]

Properties

The JUNQ is a non- membrane bound cellular site located in a margin of the nucleus, in close proximity to the endoplasmic reticulum. FRAP and FLIP assays revealed that proteins in the JUNQ are soluble and exchange with the cytosol, suggesting that the JUNQ has a dynamic structure.

Delivery to the JUNQ depends on molecular chaperones and co-chaperones and on the actin cytoskeleton. [4] Misfolded proteins must be ubiquitinated to be sorted to the JUNQ. If ubiquitination is blocked, a misfolded protein will be directed to the IPOD inclusion. Misfolded protein accumulation recruits 26S proteasomes to the JUNQ.

IPOD

IPOD is the Insoluble Protein Deposit compartment.

An IPOD inclusion viewed by a non-ubiquitinated VHL protein(red), tethered to the vacuole (green). IPOD (red) tethered to the vacuole (green).tif
An IPOD inclusion viewed by a non-ubiquitinated VHL protein(red), tethered to the vacuole (green).

Significance

It is becoming more evident that the cellular capacity to maintain proteostasis [8] declines with age, [9] thereby causing the late onset of neurodegenerative diseases. In such diseases (e.g. Huntington's disease), a mutated protein misfolds and becomes toxic to the cellular environment by various ways such as denaturating cytosolic proteins. [14] Incompetent of degrading those toxic species, the cell must isolate them to avoid their hazardous interaction with the cellular proteome. The IPOD was shown [3] to be the sub-cellular site to which toxic amyloidogenic proteins are sequestered to, hereby serving as a protective quality control compartment.

In addition, it was suggested by the Lindquist group, that the IPOD is the site where yeast prions undergo a maturation process. [15] Thus, the IPOD may serve not only as a sequestration site, but also as a functional compartment. [15]

Properties

The IPOD is a non- membrane bound cellular site, which in yeast is located by the vacuole. FRAP and FLIP assays revealed that proteins in the IPOD are tightly packed, in-soluble and don't exchange with the cytosol. Amyloidogenic proteins, such as the Huntingtin protein, are the IPOD's substrates.[ citation needed ]

Misfolded proteins must be non-ubiquitinated to be sorted to the IPOD. Ubiquitination of an otherwise IPOD substrate, such as the RNQ1 fungal prion, will result in its sequestration in the JUNQ inclusion.[ citation needed ]

Upon accumulation of misfolded proteins, the disaggregase chaperone, AAA protein HSP104, localizes to the IPOD. It is yet to be determined if HSP104 functions in the IPOD or is simply sequestered there being hooked to a substrate.

The pre-autophagosomal structure (PAS) is localized by the IPOD. [16] However, it wasn't shown that IPOD substrates are delivered to the vacuole, and so the link between the IPOD and autophagy is yet to be determined. [3]

See also

Related Research Articles

<span class="mw-page-title-main">Proteasome</span> Protein complexes which degrade unnecessary or damaged proteins by proteolysis

Proteasomes are protein complexes which degrade unneeded or damaged proteins by proteolysis, a chemical reaction that breaks peptide bonds. Enzymes that help such reactions are called proteases.

<span class="mw-page-title-main">Chaperone (protein)</span> Proteins assisting in protein folding

In molecular biology, molecular chaperones are proteins that assist the conformational folding or unfolding of large proteins or macromolecular protein complexes. There are a number of classes of molecular chaperones, all of which function to assist large proteins in proper protein folding during or after synthesis, and after partial denaturation. Chaperones are also involved in the translocation of proteins for proteolysis.

<span class="mw-page-title-main">AAA proteins</span> Protein family

AAA proteins or ATPases Associated with diverse cellular Activities are a protein family sharing a common conserved module of approximately 230 amino acid residues. This is a large, functionally diverse protein family belonging to the AAA+ protein superfamily of ring-shaped P-loop NTPases, which exert their activity through the energy-dependent remodeling or translocation of macromolecules.

<span class="mw-page-title-main">Heat shock response</span> Type of cellular stress response

The heat shock response (HSR) is a cell stress response that increases the number of molecular chaperones to combat the negative effects on proteins caused by stressors such as increased temperatures, oxidative stress, and heavy metals. In a normal cell, proteostasis must be maintained because proteins are the main functional units of the cell. Many proteins take on a defined configuration in a process known as protein folding in order to perform their biological functions. If these structures are altered, critical processes could be affected, leading to cell damage or death. The heat shock response can be employed under stress to induce the expression of heat shock proteins (HSP), many of which are molecular chaperones, that help prevent or reverse protein misfolding and provide an environment for proper folding.

Inclusion bodies are aggregates of specific types of protein found in neurons, a number of tissue cells including red blood cells, bacteria, viruses, and plants. Inclusion bodies of aggregations of multiple proteins are also found in muscle cells affected by inclusion body myositis and hereditary inclusion body myopathy.

<span class="mw-page-title-main">Fungal prion</span> Prion that infects fungal hosts

A fungal prion is a prion that infects hosts which are fungi. Fungal prions are naturally occurring proteins that can switch between multiple, structurally distinct conformations, at least one of which is self-propagating and transmissible to other prions. This transmission of protein state represents an epigenetic phenomenon where information is encoded in the protein structure itself, instead of in nucleic acids. Several prion-forming proteins have been identified in fungi, primarily in the yeast Saccharomyces cerevisiae. These fungal prions are generally considered benign, and in some cases even confer a selectable advantage to the organism.

<span class="mw-page-title-main">Viroplasm</span>

A viroplasm, sometimes called "virus factory" or "virus inclusion", is an inclusion body in a cell where viral replication and assembly occurs. They may be thought of as viral factories in the cell. There are many viroplasms in one infected cell, where they appear dense to electron microscopy. Very little is understood about the mechanism of viroplasm formation.

<span class="mw-page-title-main">Endoplasmic-reticulum-associated protein degradation</span>

Endoplasmic-reticulum-associated protein degradation (ERAD) designates a cellular pathway which targets misfolded proteins of the endoplasmic reticulum for ubiquitination and subsequent degradation by a protein-degrading complex, called the proteasome.

In eukaryotic cells, an aggresome refers to an aggregation of misfolded proteins in the cell, formed when the protein degradation system of the cell is overwhelmed. Aggresome formation is a highly regulated process that possibly serves to organize misfolded proteins into a single location.

The unfolded protein response (UPR) is a cellular stress response related to the endoplasmic reticulum (ER) stress. It has been found to be conserved between mammalian species, as well as yeast and worm organisms.

<span class="mw-page-title-main">STUB1</span> Protein-coding gene in the species Homo sapiens

STUB1 is a human gene that codes for the protein CHIP.

<span class="mw-page-title-main">PSMC6</span> Enzyme found in humans

26S protease regulatory subunit S10B, also known as 26S proteasome AAA-ATPase subunit Rpt4, is an enzyme that in humans is encoded by the PSMC6 gene. This protein is one of the 19 essential subunits of a complete assembled 19S proteasome complex Six 26S proteasome AAA-ATPase subunits together with four non-ATPase subunits form the base sub complex of 19S regulatory particle for proteasome complex.

<span class="mw-page-title-main">KDELR1</span> Protein-coding gene in the species Homo sapiens

KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1, also known as KDELR1, is a protein which in humans is encoded by the KDELR1 gene.

<span class="mw-page-title-main">Protein aggregation</span> Accumulation of clumps of misfolded or disordered proteins

In molecular biology, protein aggregation is a phenomenon in which intrinsically-disordered or mis-folded proteins aggregate either intra- or extracellularly. Protein aggregates have been implicated in a wide variety of diseases known as amyloidoses, including ALS, Alzheimer's, Parkinson's and prion disease.

Richard I. Morimoto is a Japanese American molecular biologist. He is the Bill and Gayle Cook Professor of Biology and Director of the Rice Institute for Biomedical Research at Northwestern University.

Proteostasis is the dynamic regulation of a balanced, functional proteome. The proteostasis network includes competing and integrated biological pathways within cells that control the biogenesis, folding, trafficking, and degradation of proteins present within and outside the cell. Loss of proteostasis is central to understanding the cause of diseases associated with excessive protein misfolding and degradation leading to loss-of-function phenotypes, as well as aggregation-associated degenerative disorders. Therapeutic restoration of proteostasis may treat or resolve these pathologies.

Chaperone-assisted selective autophagy is a cellular process for the selective, ubiquitin-dependent degradation of chaperone-bound proteins in lysosomes.

Chaperome refers to the ensemble of all cellular molecular chaperone and co-chaperone proteins that assist protein folding of misfolded proteins or folding intermediates in order to ensure native protein folding and function, to antagonize aggregation-related proteotoxicity and ensuing protein loss-of-function or protein misfolding-diseases such as the neurodegenerative diseases Alzheimer's, Huntington's or Parkinson's disease, as well as to safeguard cellular proteostasis and proteome balance.

The mitochondrial unfolded protein response (UPRmt) is a cellular stress response related to the mitochondria. The UPRmt results from unfolded or misfolded proteins in mitochondria beyond the capacity of chaperone proteins to handle them. The UPRmt can occur either in the mitochondrial matrix or in the mitochondrial inner membrane. In the UPRmt, the mitochondrion will either upregulate chaperone proteins or invoke proteases to degrade proteins that fail to fold properly. UPRmt causes the sirtuin SIRT3 to activate antioxidant enzymes and mitophagy.

Anne Bertolotti is a French biochemist and cell biologist who works as Programme Leader at the MRC Laboratory of Molecular Biology in Cambridge, UK. In 2022 she was appointed Head of the MRC LMB's Neurobiology Division. She is known for her research into the cellular defences against misfolded proteins and the mechanisms underlying their deposition, the molecular problem causative of neurodegenerative diseases.

References

  1. ↑ Treusch, Sebastian; Cyr, Douglas M.; Lindquist, Susan (2009). "Amyloid deposits: Protection against toxic protein species?" (PDF). Cell Cycle. 8 (11): 1668–74. doi:10.4161/cc.8.11.8503. PMC   4451085 . PMID   19411847.
  2. 1 2 3 Tyedmers, Jens; Mogk, Axel; Bukau, Bernd (2010). "Cellular strategies for controlling protein aggregation". Nature Reviews Molecular Cell Biology. 11 (11): 777–88. doi:10.1038/nrm2993. PMID   20944667. S2CID   22449895.
  3. 1 2 3 4 5 6 Kaganovich, Daniel; Kopito, Ron; Frydman, Judith (2008). "Misfolded proteins partition between two distinct quality control compartments". Nature. 454 (7208): 1088–95. Bibcode:2008Natur.454.1088K. doi:10.1038/nature07195. PMC   2746971 . PMID   18756251.
  4. 1 2 Specht, S.; Miller, S. B. M.; Mogk, A.; Bukau, B. (2011). "Hsp42 is required for sequestration of protein aggregates into deposition sites in Saccharomyces cerevisiae". The Journal of Cell Biology. 195 (4): 617–29. doi:10.1083/jcb.201106037. PMC   3257523 . PMID   22065637.
  5. ↑ Ogrodnik M, Salmonowicz H, Brown R, Turkowska J, Sredniawa W, Pattabiraman S, Amen T, Abraham AC, Eichler N, Lyakhovetsky R, Kaganovich D (2014). "Dynamic JUNQ inclusion bodies are asymmetrically inherited in mammalian cell lines through the asymmetric partitioning of vimentin". Proceedings of the National Academy of Sciences of the United States of America . 111 (22): 8049–54. Bibcode:2014PNAS..111.8049O. doi: 10.1073/pnas.1324035111 . PMC   4050583 . PMID   24843142.
  6. ↑ Nystrom, T. (2010). "Spatial protein quality control and the evolution of lineage-specific ageing". Philosophical Transactions of the Royal Society B: Biological Sciences. 366 (1561): 71–5. doi:10.1098/rstb.2010.0282. PMC   3001311 . PMID   21115532.
  7. ↑ Morimoto, R. I.; Cuervo, A. M. (2009). "Protein Homeostasis and Aging: Taking Care of Proteins from the Cradle to the Grave". The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 64A (2): 167–70. doi:10.1093/gerona/gln071. PMC   2655025 . PMID   19228787.
  8. 1 2 Powers, Evan T.; Morimoto, Richard I.; Dillin, Andrew; Kelly, Jeffery W.; Balch, William E. (2009). "Biological and Chemical Approaches to Diseases of Proteostasis Deficiency". Annual Review of Biochemistry. 78: 959–91. doi:10.1146/annurev.biochem.052308.114844. PMID   19298183.
  9. 1 2 Ben-Zvi, A.; Miller, E. A.; Morimoto, R. I. (2009). "Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging". Proceedings of the National Academy of Sciences. 106 (35): 14914–9. Bibcode:2009PNAS..10614914B. doi: 10.1073/pnas.0902882106 . JSTOR   40484529. PMC   2736453 . PMID   19706382.
  10. ↑ "Live-Cell Imaging".
  11. 1 2 Lippincott-Schwartz, J.; Patterson, GH (2003). "Development and Use of Fluorescent Protein Markers in Living Cells". Science. 300 (5616): 87–91. Bibcode:2003Sci...300...87L. doi:10.1126/science.1082520. PMID   12677058. S2CID   7831723.
  12. ↑ Seufert, W.; Seufert, W (1996). "A Yeast Ubc9 Mutant Protein with Temperature-sensitive in Vivo Function is Subject to Conditional Proteolysis by a Ubiquitin- and Proteasome-dependent Pathway". Journal of Biological Chemistry. 271 (42): 25790–6. doi: 10.1074/jbc.271.42.25790 . PMID   8824207.
  13. ↑ Tongaonkar, Prasad; Beck, Konrad; Shinde, Ujwal P.; Madura, Kiran (1999). "Characterization of a Temperature-Sensitive Mutant of a Ubiquitin-Conjugating Enzyme and Its Use as a Heat-Inducible Degradation Signal". Analytical Biochemistry. 272 (2): 263–9. doi:10.1006/abio.1999.4190. PMID   10415098.
  14. ↑ England, Jeremy L.; Kaganovich, Daniel (2011). "Polyglutamine shows a urea-like affinity for unfolded cytosolic protein". FEBS Letters. 585 (2): 381–4. doi: 10.1016/j.febslet.2010.12.023 . PMID   21176779. S2CID   348468.
  15. 1 2 Tyedmers, J.; Treusch, S.; Dong, J.; McCaffery, J. M.; Bevis, B.; Lindquist, S. (2010). "Prion induction involves an ancient system for the sequestration of aggregated proteins and heritable changes in prion fragmentation". Proceedings of the National Academy of Sciences. 107 (19): 8633–8. Bibcode:2010PNAS..107.8633T. doi: 10.1073/pnas.1003895107 . PMC   2889312 . PMID   20421488.
  16. ↑ Suzuki, K.; Kirisako, T; Kamada, Y; Mizushima, N; Noda, T; Ohsumi, Y (2001). "The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation". The EMBO Journal. 20 (21): 5971–81. doi:10.1093/emboj/20.21.5971. PMC   125692 . PMID   11689437.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.